> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Docket Created for Biomarkers Used in Novel Drug/Biologic Approvals
- URL: https://www.fdaweb.com/docket-created-for-biomarkers-used-in-novel-drug-biologic-approvals/
- Published: 2016-09-19T12:00:00.000Z
- Updated: 2026-09-14T21:33:12.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5136841

*Federal Register* Notice: FDA has established a docket to receive suggestions, recommendations, and comments on a list of biomarkers that were used as outcomes to develop FDA-approved new molecular entities and biological therapeutics from 2007 to 2015\. Comments received on the list will help FDA determine the utility of the list and may assist FDA in developing databases on biomarkers for drug development in the future. To view this notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2016-09-19/pdf/2016-22470.pdf?ref=fdaweb.com).